EuroPacific Growth Fund - Class R2E (REEBX)
The EuroPacific Growth Fund - Class R2E (ticker: REEBX) is a mutual fund that focuses on investing in companies located in Europe and the Pacific region. This fund aims for long-term growth by investing in a diverse range of industries and sectors within these regions. The Class R2E shares are designed for investors who are looking for a lower expense ratio and have a longer investment horizon. With a focus on international markets, this fund offers investors the opportunity to diversify their portfolio and potentially benefit from the growth of economies outside of the United States.
REEBX Mutual Fund Chart & Stats
- Previous Close
- $59.28
- Sub-Category
- Global,International
- Total Liabilities
- $1.37B
- Expense Ratio
- 1.27%
- Holding Count
- 391
- Brand
- Eupac Fund
- Category
- Equity
- Total Assets
- 142.26B
- Shares Outstanding
- N/A
- 52-Week Range
- $55.86 - $66.26
REEBX Mutual Fund News
AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World Insights and Decision Guidance Evaluation (BRIDGE-HK) An Observational, Retrospective,
AstraZeneca Updates AZD4144 Drug-Interaction Study: What Investors Need to Know
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s NCT07685600 study, officially titled “An Open-label, Randomised, Two Arm, Fixed Sequence Study in Healthy Participants to
Top 10 Holdings
| Name | Weight % |
|---|---|
| 2330TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 7.44% |
| 000660SK hynix Inc. | 5.39% |
| USD_CASHCAPITAL GROUP CENTRAL CASH FUND | 3.39% |
| ASMLASML Holding NV | 2.41% |
| 9984SoftBank Group Corp | 1.86% |
| UCGUniCredit S.p.A | 1.40% |
| AZNAstraZeneca plc | 1.31% |
| CVECenovus Energy | 1.28% |
| AIRAirbus Group | 1.26% |
| 005930Samsung Electronics Co. Ltd. | 1.25% |
| Total | 26.98% |
Recently Viewed
No data currently available












